AREC — Arecor Therapeutics Cashflow Statement
0.000.00%
Last trade - 00:00- £39.36m
- £31.29m
- £2.40m
Annual cashflow statement for Arecor Therapeutics, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.
2018 May 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 7 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -1.43 | -1.57 | -3.51 | -6.95 | -10.5 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 0.321 | 0.286 | 0.445 | 0.985 | 0.346 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.439 | 0.928 | 1.04 | 0.339 | -0.925 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Payable / Accrued Expenses | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -0.493 | -0.268 | -1.86 | -5.45 | -10.8 |
| Capital Expenditures | -0.013 | -0.019 | -0.052 | -0.069 | -0.345 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 0 | 0.005 | 0.003 | 0.001 | -7.65 |
| Sale of Business | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.013 | -0.013 | -0.049 | -0.068 | -7.99 |
| Financing Cash Flow Items | -0.025 | -0.008 | -0.083 | -1.46 | -0.38 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.217 | -0.076 | 1.77 | 20.9 | 5.16 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.323 | -0.373 | -0.175 | 15.4 | -13.6 |